Design of a phase 3 clinical trial of the oral p38α kinase inhibitor neflamapimod in patients with dementia with Lewy bodies (DLB)

neflamapimod (VX-745) - CervoMed

James GALVIN 1; John-Paul TAYLOR 2, Nathalie ADDA 3, Amanda GARDNER 3, Shannon BRADLEY 3, Kelly BLACKBURN 3, John J ALAM 3

Aug 3, 2026